Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Mounjaro (tirzepatide) and Wegovy (semaglutide) have transformed weight loss treatment, but they are not identical medications. While both activate GLP-1 pathways to reduce appetite and improve metabolic control, tirzepatide targets an additional receptor called GIP, which may explain why clinical trials show tirzepatide users lose more weight on average than semaglutide users.
How Tirzepatide and Semaglutide Work Differently
Semaglutide, the active ingredient in Wegovy, stimulates only the GLP-1 receptor. This pathway helps regulate blood sugar, reduces hunger signals in the brain, and slows stomach emptying so you feel full longer. The medication has been studied extensively in people with type 2 diabetes and obesity, making it a well-established option with decades of safety data behind it.
Tirzepatide, found in Mounjaro, is a dual-action medication that activates both GLP-1 and GIP receptors. The GIP receptor plays a role in energy regulation and may enhance how your body burns calories. This dual mechanism means tirzepatide has two pathways to reduce appetite and support weight loss simultaneously, rather than one.
The addition of GIP receptor activation in tirzepatide is why many patients and providers view it as a more potent option. However, individual response varies based on your unique genetic makeup, metabolism, and how your body's peptide pathways respond to each medication.
Weight Loss Results: Clinical Trial Comparisons
In the STEP trials, semaglutide users at the highest dose lost approximately 15% of their body weight over 68 weeks. This represents meaningful weight loss for most patients and has been shown to reduce the risk of major cardiovascular events in people with existing heart disease or stroke history.
The SURMOUNT trials examined tirzepatide and found weight loss ranging from 16% to 22% of body weight depending on the dose, over a similar timeframe. At the highest dose tested, tirzepatide users lost substantially more weight than semaglutide users in head-to-head comparisons, though individual results vary considerably.
Neither medication works the same way in every person. Some patients respond better to semaglutide, while others see superior results with tirzepatide. Genetic factors—including variations in your GLP1R and GIPR genes—influence how effectively each medication works for your body specifically.
Side Effects and Tolerability Differences
Both tirzepatide and semaglutide carry similar side effect profiles: nausea, vomiting, diarrhea, and constipation are most common, particularly when doses increase. Most patients experience milder symptoms as their bodies adjust over several weeks. Serious side effects are rare but include pancreatitis and gallbladder problems.
Some patients report that tirzepatide causes slightly more gastrointestinal discomfort initially because it works through two receptor pathways simultaneously. However, starting at a lower dose and increasing gradually—a strategy PlexusDx supports through its Microdose GLP-1 Protocol at $129/month—can minimize side effects while your body adapts.
The choice between these medications often depends on how well you tolerate each one. Someone who experiences severe nausea on tirzepatide might find semaglutide more manageable, or vice versa. Your personal tolerance and medical history should guide the decision alongside clinical effectiveness data.
Cost, Access, and Personalization at PlexusDx
PlexusDx offers compounded tirzepatide injections starting at $249 per month, with no insurance required and access across all 50 states. Unlike brand-name Mounjaro or Wegovy, compounded versions from licensed 503A pharmacies cost significantly less while delivering the same active medications. Your dose may need to go up as your body adapts—your price won't.
For patients who prefer oral medications, PlexusDx provides both oral semaglutide starting at $249/month and oral tirzepatide at $279/month. The GLP-Squared Injection option combines both compounds at $249/month, allowing some patients to benefit from dual GLP-1 and GIP activation through a single medication.
PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify which of 14 pathways and 49 peptides your body responds to most effectively. Key genetic markers like GLP1R rs6923761 and GIPR rs1800437 predict how well tirzepatide versus semaglutide will work for you before you invest months of treatment.
Which Medication Should You Choose?
Clinical evidence suggests tirzepatide produces greater average weight loss than semaglutide, making it the stronger choice if maximum weight loss is your primary goal. However, 'better' is personal: if semaglutide works well for your body with fewer side effects, the smaller average weight loss difference may not matter in practice.
Patients with significant insulin resistance or metabolic dysfunction sometimes see better results with tirzepatide's dual pathway approach. Conversely, those with mild insulin resistance or gastrointestinal sensitivity might find semaglutide sufficient and easier to tolerate.
PlexusDx supports informed decision-making by offering both medications at transparent, flat monthly prices with no flat per-compound pricing increases. Starting with genetic testing through the Precision Peptide test can illuminate which medication aligns with your unique peptide pathway genetics, improving the likelihood of success before you commit to treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does Mounjaro really cause more weight loss than Wegovy?
Clinical trials show tirzepatide (Mounjaro) users lost 16–22% of body weight versus 15% for semaglutide (Wegovy) users at their highest doses. However, individual results vary significantly based on genetics, metabolism, and adherence. Some patients achieve excellent results on semaglutide alone.
Can I switch from Wegovy to Mounjaro if Wegovy isn't working?
Yes, many patients switch between semaglutide and tirzepatide if they plateau or want stronger results. PlexusDx offers both medications at flat monthly rates ($249/month for tirzepatide injection, $249/month for oral semaglutide), allowing flexibility without additional cost barriers.
Is compounded tirzepatide at PlexusDx the same as brand-name Mounjaro?
PlexusDx tirzepatide comes from licensed 503A compounding pharmacies and contains the same active ingredient as Mounjaro. The key difference is cost: PlexusDx starts at $249/month without insurance requirements, versus hundreds more for brand Mounjaro. Both require a prescription.
What if I experience bad side effects from tirzepatide?
Nausea and GI upset are common initially but usually improve within weeks. PlexusDx's Microdose GLP-1 Protocol ($129/month) starts at lower doses to minimize side effects while your body adjusts. If tirzepatide remains intolerable, switching to semaglutide (oral or injection) is a straightforward option.
How does the Precision Peptide Genetic Test help me choose between these medications?
The test ($99 add-on) analyzes your GLP1R and GIPR genes plus 14 other pathway variants to predict how strongly you'll respond to each medication. Patients with favorable GIPR variants often respond better to tirzepatide's dual-receptor activation, while others may achieve equal results on semaglutide alone.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What to Take for Nausea from Zepbound: Effective Management Strategies
Understanding Ozempic Clearance: How Long Does It Take Ozempic To Leave The Body?